Literature DB >> 16969145

Hyperthyroidism: a rare cause of reversible pulmonary hypertension.

Rock Wasseem1, Elias Mazen, Saliba R Walid.   

Abstract

We describe a case of pulmonary hypertension and high-output heart failure in a 61-year-old woman suffering from relapsing Graves disease. The patient experienced prompt hemodynamic and symptomatic recovery after normal thyroid function was restored. Possible mechanisms for the development of pulmonary arterial hypertension due to hyperthyroidism include damage to pulmonary vascular endothelium due to high cardiac output or an autoimmune process or increased metabolism of intrinsic pulmonary vasodilators. Another possible mechanism is vascular vasoconstriction due to decreased cholinergic output.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969145     DOI: 10.1097/00000441-200609000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

1.  Impact of achieving euthyroidism on pulmonary artery systolic pressures in hyperthyroidism-associated pulmonary hypertension - a systematic review.

Authors:  Shireen R Chacko; Pradhum Ram; Tamaryn Fox; Naveen Sooknanan; Kevin Bryan Lo; Ritesh G Menezes; Savita Lasrado; Glenn Eiger; Anjali Vaidya
Journal:  Am J Cardiovasc Dis       Date:  2022-08-15

2.  Graves' disease--familiar foe, unfamiliar face.

Authors:  Sadishkumar Kamalanathan; Karthik Balachandran; Gobu Packirisamy; Abdoul Hamide
Journal:  BMJ Case Rep       Date:  2012-08-01

3.  Isolated right ventricular failure in hyperthyroidism: a clinical dilemma.

Authors:  Ryan J McDonough; Marvin S Moul; Darrick Beckman; Ahmad M Slim
Journal:  Heart Int       Date:  2011-10-21

4.  Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.

Authors:  Larisse Vieira Mendes Araruna; Daniela Camargo de Oliveira; Mônica Corso Pereira; Arnaldo Moura Neto; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-06       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.